Literature DB >> 32381547

MRI Signal Intensity and Electron Ultrastructure Classification Predict the Long-Term Outcome of Skull Base Chordomas.

J Bai1,2,3, J Shi4, S Zhang2,5, C Zhang2, Y Zhai2,6, S Wang2, M Li2, C Li2, P Zhao1,3, S Geng1,3, S Gui1,3, L Jing7, Y Zhang8,2,3.   

Abstract

BACKGROUND AND
PURPOSE: MR imaging is a useful and widely used evaluation for chordomas. Prior studies have classified chordomas into cell-dense type and matrix-rich type according to the ultrastructural features. However, the relationship between the MR imaging signal intensity and ultrastructural classification is unknown. We hypothesized that MR imaging signal intensity may predict both tumor ultrastructural classification and prognosis.
MATERIALS AND METHODS: Seventy-nine patients with skull base chordomas who underwent 95 operations were included in this retrospective single-center series. Preoperative tumor-to-pons MR imaging signal intensity ratios were calculated and designated as ratio on T1 FLAIR sequence (RT1), ratio on T2 sequence (RT2), and ratio on enhanced T1 FLAIR sequence (REN), respectively. We assessed the relationships among signal intensity ratios, ultrastructural classification, and survival.
RESULTS: Compared with the matrix-rich type group, the cell-dense type chordomas showed lower RT2 (cell-dense type: 1.90 ± 0.38; matrix-rich type: 2.61 ± 0.60 P < .001). The model of predicting cell-dense type based on RT2 had an area under the curve of 0.83 (95% CI, 0.75-0.92). In patients without radiation therapy, both progression-free survival (P = .003) and overall survival (P = .002) were longer in the matrix-rich type group than in the cell-dense type group. REN was a risk factor for progression-free survival (hazard ratio = 10.24; 95% CI, 1.73-60.79); RT2 was a protective factor for overall survival (hazard ratio  = 0.33; 95% CI, 0.12-0.87); and REN was a risk factor for overall survival (hazard ratio = 4.76; 95% CI, 1.51-15.01).
CONCLUSIONS: The difference in MR imaging signal intensity in chordomas can be explained by electron microscopic features. Both signal intensity ratios and electron microscopic features may be prognostic factors.
© 2020 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2020        PMID: 32381547      PMCID: PMC7228160          DOI: 10.3174/ajnr.A6557

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  28 in total

1.  Analysis of clinical factors and PDGFR-β in predicting prognosis of patients with clival chordoma.

Authors:  Yixuan Zhai; Jiwei Bai; Shuai Wang; Hua Gao; Mingxuan Li; Chuzhong Li; Songbai Gui; Yazhuo Zhang
Journal:  J Neurosurg       Date:  2018-12-01       Impact factor: 5.115

2.  Pediatric Chordomas: Results of a Multicentric Study of 40 Children and Proposal for a Histopathological Prognostic Grading System and New Therapeutic Strategies.

Authors:  Kévin Beccaria; Arnault Tauziède-Espariat; Franck Monnien; Homa Adle-Biassette; Julien Masliah-Planchon; Gaëlle Pierron; Laetitia Maillot; Marc Polivka; Annie Laquerrière; Sandrine Bouillot-Eimer; Edouard Gimbert; Guillaume Gauchotte; Laurent Coffinet; Henri Sevestre; Claire Alapetite; Stéphanie Bolle; Dominic Thompson; Schahrazed Bouazza; Bernard George; Michel Zérah; Christian Sainte-Rose; Stéphanie Puget; Pascale Varlet
Journal:  J Neuropathol Exp Neurol       Date:  2018-03-01       Impact factor: 3.685

3.  Predictive Value of Transforming Growth Factor-α and Ki-67 for the Prognosis of Skull Base Chordoma.

Authors:  Shuheng Zhang; Jiwei Bai; Mingxuan Li; Yixuan Zhai; Shuai Wang; Qian Liu; Chuzhong Li; Songbai Gui; Yazhuo Zhang
Journal:  World Neurosurg       Date:  2019-05-21       Impact factor: 2.104

Review 4.  Radiologic and pathologic findings in breast tumors with high signal intensity on T2-weighted MR images.

Authors:  Gorane Santamaría; Martín Velasco; Xavier Bargalló; Xavier Caparrós; Blanca Farrús; Pedro Luis Fernández
Journal:  Radiographics       Date:  2010-03       Impact factor: 5.333

5.  Sacrococcygeal chordoma: MR imaging in 30 patients.

Authors:  Mi Sook Sung; Gyung Kyu Lee; Heung Sik Kang; Soon Tae Kwon; Jin Gyoon Park; Jin Suk Suh; Gil Ho Cho; Sung Moon Lee; Myung Hee Chung; Donald Resnick
Journal:  Skeletal Radiol       Date:  2004-10-08       Impact factor: 2.199

6.  Prognostic Implications of Gadolinium Enhancement of Skull Base Chordomas.

Authors:  E Lin; T Scognamiglio; Y Zhao; T H Schwartz; C D Phillips
Journal:  AJNR Am J Neuroradiol       Date:  2018-06-14       Impact factor: 3.825

7.  Prognostic significance of MRI findings in patients with myxoid-round cell liposarcoma.

Authors:  Ukihide Tateishi; Tadashi Hasegawa; Yasuo Beppu; Akira Kawai; Mitsuo Satake; Noriyuki Moriyama
Journal:  AJR Am J Roentgenol       Date:  2004-03       Impact factor: 3.959

8.  Differences in Dural Penetration of Clival Chordomas Are Associated with Different Prognosis and Expression of Platelet-Derived Growth Factor Receptor-β.

Authors:  Yixuan Zhai; Jiwei Bai; Shuai Wang; Jiang Du; Jichao Wang; Chuzhong Li; Songbai Gui; Yazhuo Zhang
Journal:  World Neurosurg       Date:  2016-08-06       Impact factor: 2.104

9.  Diffusion-weighted MRI: distinction of skull base chordoma from chondrosarcoma.

Authors:  K W Yeom; R M Lober; B C Mobley; G Harsh; H Vogel; R Allagio; M Pearson; M S B Edwards; N J Fischbein
Journal:  AJNR Am J Neuroradiol       Date:  2012-11-01       Impact factor: 3.825

10.  Clinicopathologic characteristics of poorly differentiated chordoma.

Authors:  Angela R Shih; Gregory M Cote; Ivan Chebib; Edwin Choy; Thomas DeLaney; Vikram Deshpande; Francis J Hornicek; Ruoyu Miao; Joseph H Schwab; G Petur Nielsen; Yen-Lin Chen
Journal:  Mod Pathol       Date:  2018-02-26       Impact factor: 7.842

View more
  2 in total

1.  Radiomics and Dosiomics for Predicting Local Control after Carbon-Ion Radiotherapy in Skull-Base Chordoma.

Authors:  Giulia Buizza; Chiara Paganelli; Emma D'Ippolito; Giulia Fontana; Silvia Molinelli; Lorenzo Preda; Giulia Riva; Alberto Iannalfi; Francesca Valvo; Ester Orlandi; Guido Baroni
Journal:  Cancers (Basel)       Date:  2021-01-18       Impact factor: 6.639

2.  Differentiation Between Primary Central Nervous System Lymphoma and Atypical Glioblastoma Based on MRI Morphological Feature and Signal Intensity Ratio: A Retrospective Multicenter Study.

Authors:  Yu Han; Zi-Jun Wang; Wen-Hua Li; Yang Yang; Jian Zhang; Xi-Biao Yang; Lin Zuo; Gang Xiao; Sheng-Zhong Wang; Lin-Feng Yan; Guang-Bin Cui
Journal:  Front Oncol       Date:  2022-01-31       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.